Generate Biomedicines, Inc. (GENB) stock
GENBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$9.84−0.65 (-6.20%)
Close on Nov 17, 2026Market cap $1.26BP/E –Yield –
Generate Biomedicines total assets
Total assets on the balance sheet at the end of each period.
Generate Biomedicines's total assets was $515.89M at Sep 30, 2026. For fiscal 2025 it was $330.18M.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $330.18M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $515.89M | – |
| Q2 FY2026 | Jun 30, 2026 | $561.69M | – |
| Q1 FY2026 | Mar 31, 2026 | $625.74M | – |
| Q4 FY2025 | Dec 31, 2025 | $330.18M | – |
See a number that looks wrong?